Startseite Update on multiple sclerosis, its diagnosis and treatments
Artikel Öffentlich zugänglich

Update on multiple sclerosis, its diagnosis and treatments

  • Anne H. Cross

    Anne H. Cross obtained her MD degree from the University of Alabama. She trained in neurology at the George Washington University, followed by fellowships in neuroimmunology at the US National Institutes of Health and neuropathology at Albert Einstein College of Medicine. In 1990, she was honored with the Harry Weaver Neuroscience Award from the National MS Society. Joining the Neurology faculty at Washington University in 1991, Dr. Cross currently serves as Section Head of Neuroimmunology. Dr. Cross has devoted her career to the study of MS, care of MS patients and training of future clinicians and researcher in the neuroimmunology field. She is the author of over 150 publications, most of which have focused on MS.

    EMAIL logo
    , Kevin A. Cross

    Kevin A. Cross is a student at Vanderbilt University in Nashville, Tennessee, where he is majoring in history and German. During his university years, he worked each summer doing medical research, ranging from animal studies utilizing the animal model for MS, experimental autoimmune encephalomyelitis, to advanced imaging studies to quantitate MRI in MS. He plans to attend medical school in the future.

    und Laura Piccio

    Laura Piccio obtained her MD and PhD degrees from the University of Milan, Italy where she trained as a neurologist. In 2005 she received a post-doctoral fellowship from the National Multiple Sclerosis Society (NMSS) under the mentorship of Dr. Anne Cross at Washington University. In 2008, she joined the faculty of the Neuroimmunology Section of the Department of Neurology at Washington University. She was awarded the prestigious Harry Weaver Neuroscience Award from the NMSS in 2010. At present, her research interests are focused on the role of innate immunity in MS, and the interplay between metabolic and immune pathways in MS and its animal model.

Veröffentlicht/Copyright: 7. März 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Received: 2011-10-10
Accepted: 2012-01-12
Published Online: 2012-03-07
Published in Print: 2012-07-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
  5. Reviews
  6. European medical laboratory accreditation. Present situation and steps to harmonisation
  7. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
  8. Translating exome sequencing from research to clinical diagnostics
  9. Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
  10. Pregnancy-associated plasma protein A: spotlight on kidney diseases
  11. Measurement of factor XIII activity in plasma
  12. Update on multiple sclerosis, its diagnosis and treatments
  13. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
  14. Mini Reviews
  15. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
  16. Highlights in inflammatory bowel disease – from bench to bedside
  17. Opinion Papers
  18. Implementation of standardization in clinical practice: not always an easy task
  19. IFCC standardised HbA1c: should the world be as one?
  20. Reflective testing: adding value to laboratory testing
  21. Original Articles
  22. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  23. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
  24. Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
  25. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Heruntergeladen am 14.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0736/html
Button zum nach oben scrollen